New approach to specific Alzheimer's disease diagnosis based on plasma biomarkers in a cognitive disorder cohort
The plasma GFAP levels and the validated predictive model based on plasma biomarkers represent a relevant step toward the development of a potential clinical approach for AD diagnosis, which should be assessed in further research.
Authors
- Miquel Baquero (ORCID: https://orcid.org/0000-0002-6861-1831)
- Lourdes Álvarez‐Sánchez (ORCID: https://orcid.org/0000-0002-7016-9739)
- Laura Cubas-Núñez (ORCID: https://orcid.org/0000-0003-4934-3891)
- Ángel Balaguer (ORCID: https://orcid.org/0009-0003-7317-9689)
- Laura Ferré‐González (ORCID: https://orcid.org/0000-0003-4631-4761)
- Bonaventura Casanova (ORCID: https://orcid.org/0000-0003-3806-925X)
- Carmen Peña‐Bautista (ORCID: https://orcid.org/0000-0003-3565-1148)
- Consuelo Cháfer‐Pericás (ORCID: https://orcid.org/0000-0002-0711-5877)
- Jennifer E. Amengual (ORCID: https://orcid.org/0000-0003-4117-2469)
Institutions
- Hospital Universitari i Politècnic La Fe (ES)
- Instituto de Investigación Sanitaria La Fe (ES)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1111/eci.70034
- Citations
- 4
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.66